Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svane

Showing results (371-380 of 811) with videos related to

Pageof 82
Sort By:
Molecular Therapy Oncolytics|February 10, 2022
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapyChristopher Aled Chamberlain, Eric Paul Bennett, Anders Handrup Kverneland, et al.
Acta Crystallographica. Section A, Foundations and Advances|July 3, 2019
Multipole electron densities and atomic displacement parameters in urea from accurate powder X-ray diffractionBjarke Svane, Kasper Tolborg, Lasse Rabøl Jørgensen, et al.
Trends in Cancer|March 19, 2026
Driving CAR therapies beyond T cellsCecilie Ø Madsen, Thomas M Hulen, Maria Ormhøj, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|September 10, 2016
Free Energy of Ligand Removal in the Metal-Organic Framework UiO-66Jessica K Bristow, Katrine L Svane, Davide Tiana, et al.
Bone Marrow Transplantation|August 16, 2002
Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric methodI M Svane, K Nikolajsen, S W Hansen, et al.
BMC Nephrology|February 8, 2017
Effect of large weight reductions on measured and estimated kidney functionBernt Johan von Scholten, Frederik Persson, Maria S Svane, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trialsMarco Donia, Marie Louise Kimper-Karl, Katrine Lundby Høyer, et al.
Cell and Tissue Research|September 8, 2012
Prevascularization of self-organizing engineered heart tissue by human umbilical vein endothelial cells abrogates contractile performanceClaus Svane Sondergaard, Russell Witt, Grant Mathews, et al.
Cytotherapy|March 31, 2021
The capacity of CD4<sup>+</sup> Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56Gitte Holmen Olofsson, Sara Ram Pedersen, Pia Aehnlich, et al.
Expert Opinion on Biological Therapy|April 13, 2022
Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directionsJoachim Stoltenborg Granhøj, Agnete Witness Præst Jensen, Mario Presti, et al.
Pageof 82

Showing results (371-380 of 811) with videos related to

Sort By:
Pageof 82
Molecular Therapy Oncolytics|February 10, 2022
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapyChristopher Aled Chamberlain, Eric Paul Bennett, Anders Handrup Kverneland, et al.
Acta Crystallographica. Section A, Foundations and Advances|July 3, 2019
Multipole electron densities and atomic displacement parameters in urea from accurate powder X-ray diffractionBjarke Svane, Kasper Tolborg, Lasse Rabøl Jørgensen, et al.
Trends in Cancer|March 19, 2026
Driving CAR therapies beyond T cellsCecilie Ø Madsen, Thomas M Hulen, Maria Ormhøj, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|September 10, 2016
Free Energy of Ligand Removal in the Metal-Organic Framework UiO-66Jessica K Bristow, Katrine L Svane, Davide Tiana, et al.
Bone Marrow Transplantation|August 16, 2002
Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric methodI M Svane, K Nikolajsen, S W Hansen, et al.
BMC Nephrology|February 8, 2017
Effect of large weight reductions on measured and estimated kidney functionBernt Johan von Scholten, Frederik Persson, Maria S Svane, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trialsMarco Donia, Marie Louise Kimper-Karl, Katrine Lundby Høyer, et al.
Cell and Tissue Research|September 8, 2012
Prevascularization of self-organizing engineered heart tissue by human umbilical vein endothelial cells abrogates contractile performanceClaus Svane Sondergaard, Russell Witt, Grant Mathews, et al.
Cytotherapy|March 31, 2021
The capacity of CD4<sup>+</sup> Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56Gitte Holmen Olofsson, Sara Ram Pedersen, Pia Aehnlich, et al.
Expert Opinion on Biological Therapy|April 13, 2022
Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directionsJoachim Stoltenborg Granhøj, Agnete Witness Præst Jensen, Mario Presti, et al.
Pageof 82